A gene expression profiling approach assessing celecoxib in a randomized controlled trial in prostate cancer.
BACKGROUND: We performed a pilot study, looking at the COX-2 inhibitor celecoxib, on newly diagnosed prostate cancer patients in the neo-adjuvant setting using DNA microarray analysis. PATIENTS AND METHODS: This was a single-blinded, randomized controlled phase II presurgical (radical prostatectomy...
主要な著者: | Sooriakumaran, P, Macanas-Pirard, P, Bucca, G, Henderson, A, Langley, SE, Laing, R, Smith, C, Laing, E, Coley, H |
---|---|
フォーマット: | Journal article |
言語: | English |
出版事項: |
2009
|
類似資料
-
A blinded, randomized controlled trial of neo-adjuvant celecoxib in patients with early prostate cancer.
著者:: Sooriakumaran, P, 等
出版事項: (2006) -
A randomized controlled trial investigating the effects of celecoxib in patients with localized prostate cancer.
著者:: Sooriakumaran, P, 等
出版事項: (2009) -
A blinded, randomised controlled trial of neo-adjuvant Celecoxib in patients with localised prostate cancer
著者:: Sooriakumaran, P, 等
出版事項: (2007) -
COX-2 inhibition: a possible role in the management of prostate cancer?
著者:: Sooriakumaran, P, 等
出版事項: (2007) -
A novel method of obtaining prostate tissue for gene expression profiling.
著者:: Sooriakumaran, P, 等
出版事項: (2009)